A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer

Memorial Sloan Kettering Cancer Center (MSK)

Status: Withdrawn

Conditions: Breast Cancer

Treatments: Diagnostic Test: Contrast-Enhanced Mammography; Diagnostic Test: Breast MRI

Study type: Observational

Funder types: Other

Identifiers

NCT05990478

23-224

Details and patient eligibility

About

The purpose of this study is to find out whether Contrast-Enhanced Mammography/CEM scans performed 2 minutes and 6 minutes after receiving Iohexol contrast dye can be used to identify the amount of residual disease in the breast following neoadjuvant treatment.

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any women >18 years of age at time of informed consent
• Diagnosed with breast cancer and schedule for NAT

Exclusion criteria

• History of kidney disease, creatinine level >1.3 or eGFR <45.
• Known allergic reaction to gadolinium or iodinated contrast media.
• Contraindication to contrast-enhanced breast MRI.
• Lesion not included in the field of view of either pre- or post-NAT MRI or CEM
• Presence of pacemakers or automated implantable cardioverter defibrilator
• Pregnant women

Trial design

0 participants in 1 patient group

Participants with Breast Cancer

Description:

Participants will have a diagnosis of breast cancer

Treatment:

Diagnostic Test: Breast MRI

Diagnostic Test: Contrast-Enhanced Mammography